Impact Factor 3.693 | CiteScore 2.5
More on impact ›
in Chemistry |
|
The Medicinal and Pharmaceutical Chemistry section publishes pioneering research across all aspects of medicinal chemistry and drug discovery science. It covers a broad range of topics including rational drug design and optimization, target identification and validation, imaging agents, drug delivery and pharmacology of bioactive molecules.
Read MoreThe Medicinal and Pharmaceutical Chemistry section publishes pioneering research across all aspects of medicinal chemistry and drug discovery science. It covers a broad range of topics including rational drug design and optimization, target identification and validation, imaging agents, drug delivery and pharmacology of bioactive molecules. Areas covered include, but are not limited to:
· Design, synthesis and optimization of novel biologically active molecules with significant potential as new pharmacological agents, tools, probes or potential drugs
· Molecular modifications of known chemical entities that lead to a significantly improved understanding of their structure-activity relationships
· Discovery technologies for biologically active molecules from synthetic and natural sources
· Novel and improved methodologies with broad application to medicinal chemistry
· Molecular biological studies of macromolecular targets leading to improved understanding of molecular recognition
· Novel computational, cheminformatics and structural studies for the identification or structure-activity-relationship analysis of bioactive molecules, ligands and their targets
· Effect of molecular structure on the distribution, pharmacokinetics, and metabolic transformation of biologically active compounds
· Pharmacogenetic and pharmacogenomic studies used to enhance drug design and bring new drugs to the market
All studies must contribute a mechanistic understanding of the relationship between molecular structure and biological activity or mode of action. All computational studies must demonstrate a clear use in medicinal chemistry through comparison with experimental data. Studies testing new or existing compounds as pharmacological agents must be carried out in the presence of clear positive and negative controls and include a hypothesis-driven compound design rationale. Studies presenting potential antimicrobial agents should report tests for cytotoxicity and activity against non-related pathogens.
Indexed in: PubMed Central (PMC), Scopus, Web of Science Science Citation Index Expanded (SCIE), Google Scholar, DOAJ, CrossRef, Chemical Abstracts Service (CAS), CLOCKSS
PMCID: all published articles receive a PMCID
Medicinal and Pharmaceutical Chemistry welcomes submissions of the following article types: Correction, Editorial, Mini Review, Original Research, Perspective and Review.
All manuscripts must be submitted directly to the section Medicinal and Pharmaceutical Chemistry, where they are peer-reviewed by the Associate and Review Editors of the specialty section.
Frontiers Editorial Office
Avenue du Tribunal Fédéral 34
CH – 1005 Lausanne
Switzerland
Tel +41(0)21 510 17 40
Fax +41 (0)21 510 17 01
Frontiers Support
Tel +41(0)21 510 17 10
Fax +41 (0)21 510 17 01
support@frontiersin.org
Avenue du Tribunal Fédéral 34
CH – 1005 Lausanne
Switzerland
Tel +41(0)21 510 17 40
Fax +41 (0)21 510 17 01
For all queries regarding manuscripts in Review and potential conflicts of interest, please contact chemistry.editorial.office@frontiersin.org
For queries regarding Research Topics, Editorial Board applications, and journal development, please contact chemistry@frontiersin.org
Tel +41(0)21 510 17 10
Fax +41 (0)21 510 17 01
For technical issues, please visit our Frontiers Help Center, or contact our IT HelpDesk team at support@frontiersin.org